Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - OTHER LONG-TERM ASSETS
Other Long-term Assets ALLO - Allogene Therapeutics, Inc.
16.9 M
LAST VALUE
43.26%
2 YEAR CAGR
61.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR